[S02DA03, antipyrine, The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Rivaroxaban.]
[G03XB02, ulipristal, The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Ulipristal.]
[B01AD01, streptokinase, Streptokinase may increase the anticoagulant activities of Rivaroxaban.]
[J01GA01, streptomycin, Rivaroxaban may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[L01AD04, streptozocin, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Streptozocin.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01CG01, sulbactam, Rivaroxaban may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Sulfamethoxazole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M04AB02, sulfinpyrazone, Sulfinpyrazone may increase the anticoagulant activities of Rivaroxaban.]
[M01AB02, sulindac, The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Rivaroxaban.]
[M01AX04, apazone, The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Rivaroxaban.]
[L01BB02, mercaptopurine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Mercaptopurine.]
[L02BA01, tamoxifen, The risk or severity of bleeding can be increased when Tamoxifen is combined with Rivaroxaban.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Rivaroxaban.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Dabigatran etexilate may increase the anticoagulant activities of Rivaroxaban.]
[G03BA03, testosterone, Testosterone may increase the anticoagulant activities of Rivaroxaban.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N04BC07, apomorphine, The metabolism of Rivaroxaban can be decreased when combined with Apomorphine.]
[L04AX02, thalidomide, The metabolism of Rivaroxaban can be increased when combined with Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01XX41, eribulin, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Eribulin.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01AC01, thiotepa, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Thiotepa.]
[L01BB03, thioguanine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Tioguanine.]
[G04BE06, moxisylyte, Rivaroxaban may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Rivaroxaban may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may increase the anticoagulant activities of Rivaroxaban.]
[S01ED01, timolol, Timolol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01AA12, tobramycin, Rivaroxaban may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[V04CA01, tolbutamide, Tolbutamide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M02AA21, tolmetin, The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Rivaroxaban.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N06AF04, tranylcypromine, The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Rivaroxaban.]
[C01DX11, trapidil, Trapidil may increase the anticoagulant activities of Rivaroxaban.]
[N06AX05, trazodone, The risk or severity of bleeding can be increased when Trazodone is combined with Rivaroxaban.]
[L01XF01, tretinoin, The metabolism of Rivaroxaban can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Triamcinolone.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Triazolam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Rivaroxaban may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03BA07, mometasone, The metabolism of Rivaroxaban can be increased when combined with Mometasone.]
[A03AA05, trimebutine, Rivaroxaban may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be increased when it is combined with Rivaroxaban.]
[J01FA08, troleandomycin, The metabolism of Rivaroxaban can be decreased when combined with Troleandomycin.]
[R03DX07, roflumilast, Roflumilast may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01FX04, ipilimumab, Ipilimumab may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EX04, vandetanib, Vandetanib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R02AA14, oxyquinoline, Rivaroxaban may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The metabolism of Rivaroxaban can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Rivaroxaban can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Rivaroxaban can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, Rilpivirine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AD04, urokinase, Urokinase may increase the anticoagulant activities of Rivaroxaban.]
[S01AA28, vancomycin, Rivaroxaban may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Ezogabine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, The serum concentration of Rivaroxaban can be increased when it is combined with Indacaterol.]
[B01AC24, ticagrelor, Ticagrelor may increase the anticoagulant activities of Rivaroxaban.]
[C08DA01, verapamil, The metabolism of Rivaroxaban can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Rivaroxaban can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The serum concentration of Vinblastine can be increased when it is combined with Rivaroxaban.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Rivaroxaban.]
[L01CA03, vindesine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Vindesine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[A11HA03, vitamin E, Vitamin E may increase the anticoagulant activities of Rivaroxaban.]
[B01AA03, warfarin, Warfarin may increase the anticoagulant activities of Rivaroxaban.]
[S01AA13, fusidic acid, The serum concentration of Rivaroxaban can be increased when it is combined with Fusidic acid.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Zidovudine.]
[J05AE02, indinavir, The metabolism of Rivaroxaban can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The serum concentration of Rivaroxaban can be increased when it is combined with Vemurafenib.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be increased when it is combined with Rivaroxaban.]
[M05BA05, tiludronic acid, Tiludronic acid may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B06AC02, icatibant, Icatibant may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Rivaroxaban.]
[B01AE01, desirudin, Lepirudin may increase the anticoagulant activities of Rivaroxaban.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N05AE04, ziprasidone, The metabolism of Rivaroxaban can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, The risk or severity of adverse effects can be increased when Drospirenone is combined with Rivaroxaban.]
[V03AC02, deferiprone, Rivaroxaban may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[L04AA34, alemtuzumab, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Alemtuzumab.]
[N02BA01, aspirin, Acetylsalicylic acid may increase the anticoagulant activities of Rivaroxaban.]
[L01EJ01, ruxolitinib, Rivaroxaban may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Tolterodine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DH04, doripenem, Doripenem may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L03AB11, peginterferon alfa-2a, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Peginterferon alfa-2a.]
[L01FA01, rituximab, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Rituximab.]
[J02AC03, voriconazole, The metabolism of Rivaroxaban can be decreased when combined with Voriconazole.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Rivaroxaban.]
[R07AX02, ivacaftor, The serum concentration of Rivaroxaban can be increased when it is combined with Ivacaftor.]
[H02AB11, prednylidene, The metabolism of Rivaroxaban can be increased when combined with Prednylidene.]
[B03XA04, peginesatide, Rivaroxaban may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L04AX01, azathioprine, Azathioprine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be increased when it is combined with Rivaroxaban.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Rivaroxaban.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Gemtuzumab ozogamicin.]
[A08AA11, lorcaserin, Lorcaserin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G04BD12, mirabegron, The serum concentration of Rivaroxaban can be increased when it is combined with Mirabegron.]
[L01XG02, carfilzomib, The serum concentration of Rivaroxaban can be increased when it is combined with Carfilzomib.]
[V03AX03, cobicistat, The metabolism of Rivaroxaban can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Rivaroxaban can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Rivaroxaban can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be increased when it is combined with Rivaroxaban.]
[L04AA31, teriflunomide, Teriflunomide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AX01, defibrotide, Defibrotide may increase the anticoagulant activities of Rivaroxaban.]
[L01EX05, regorafenib, Regorafenib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[D02BA02, octinoxate, Rivaroxaban may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Rivaroxaban can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Rivaroxaban.]
[N04BD02, rasagiline, The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Rivaroxaban.]
[C08CA13, lercanidipine, The metabolism of Rivaroxaban can be decreased when combined with Lercanidipine.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Rivaroxaban.]
[L04AA29, tofacitinib, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Tofacitinib.]
[V09IX04, fluorodeoxyglucose F18, Rivaroxaban may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[G04BE03, sildenafil, The risk or severity of hemorrhage can be increased when Rivaroxaban is combined with Sildenafil.]
[V08CA11, gadofosveset, Rivaroxaban may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Rivaroxaban.]
[B01AF02, apixaban, Apixaban may increase the anticoagulant activities of Rivaroxaban.]
[A16AX08, teduglutide, Rivaroxaban may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C10AX12, lomitapide, The serum concentration of Rivaroxaban can be increased when it is combined with Lomitapide.]
[A10BH04, alogliptin, Alogliptin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Rivaroxaban may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be increased when it is combined with Rivaroxaban.]
[N02BA10, benorilate, The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Rivaroxaban.]
[A10BK02, canagliflozin, The serum concentration of Rivaroxaban can be increased when it is combined with Canagliflozin.]
[A06AX06, tegaserod, The serum concentration of Rivaroxaban can be increased when it is combined with Tegaserod.]
[L03AA12, ancestim, Rivaroxaban may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Rivaroxaban.]
[L04AA18, everolimus, The serum concentration of Rivaroxaban can be increased when it is combined with Everolimus.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EC02, dabrafenib, The serum concentration of Rivaroxaban can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Rivaroxaban.]
[L01EE01, trametinib, Rivaroxaban may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Rivaroxaban may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[L01EB03, afatinib, Afatinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N06AX28, levomilnacipran, The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Rivaroxaban.]
[J05AJ03, dolutegravir, The serum concentration of Dolutegravir can be increased when it is combined with Rivaroxaban.]
[C02KX05, riociguat, The serum concentration of Riociguat can be increased when it is combined with Rivaroxaban.]
[A10BJ03, lixisenatide, Rivaroxaban may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[A05AA03, cholic acid, The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Cholic Acid.]
[C02KX04, macitentan, Rivaroxaban may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[L01EL01, ibrutinib, The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Rivaroxaban.]
[N06AX26, vortioxetine, Rivaroxaban may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Etonogestrel.]
[J05AP05, simeprevir, The metabolism of Rivaroxaban can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, The serum concentration of Sofosbuvir can be increased when it is combined with Rivaroxaban.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Rivaroxaban may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, Rivaroxaban may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[A16AA07, metreleptin, The metabolism of Rivaroxaban can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Rivaroxaban can be increased when combined with Apremilast.]
[L02BG02, formestane, Rivaroxaban may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The metabolism of Rivaroxaban can be increased when combined with Betamethasone.]
[B01AE03, argatroban, Argatroban may increase the anticoagulant activities of Rivaroxaban.]
[V03AB34, fomepizole, Fomepizole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L04AC11, siltuximab, The metabolism of Rivaroxaban can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The serum concentration of Ceritinib can be increased when it is combined with Rivaroxaban.]
[B01AC26, vorapaxar, Vorapaxar may increase the anticoagulant activities of Rivaroxaban.]
[B01AA07, acenocoumarol, Acenocoumarol may increase the anticoagulant activities of Rivaroxaban.]
[L01XH04, belinostat, The serum concentration of Rivaroxaban can be increased when it is combined with Belinostat.]
[L01EM01, idelalisib, The serum concentration of Idelalisib can be increased when it is combined with Rivaroxaban.]
[N07XX08, tafamidis, The serum concentration of Rivaroxaban can be increased when it is combined with Tafamidis.]
[L03AB13, peginterferon beta-1a, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Peginterferon beta-1a.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N05CM19, suvorexant, The serum concentration of Rivaroxaban can be increased when it is combined with Suvorexant.]
[A16AX10, eliglustat, The serum concentration of Rivaroxaban can be increased when it is combined with Eliglustat.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01BC08, decitabine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Decitabine.]
[L01EX09, nintedanib, The risk or severity of bleeding can be increased when Nintedanib is combined with Rivaroxaban.]
[S03AA06, gentamicin, Rivaroxaban may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01FX07, blinatumomab, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Blinatumomab.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Rivaroxaban.]
[B01AA01, dicumarol, Dicoumarol may increase the anticoagulant activities of Rivaroxaban.]
[B01AF03, edoxaban, The risk or severity of bleeding can be increased when Edoxaban is combined with Rivaroxaban.]
[L04AC10, secukinumab, The metabolism of Rivaroxaban can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, Palbociclib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EX08, lenvatinib, The serum concentration of Lenvatinib can be increased when it is combined with Rivaroxaban.]
[L01XH03, panobinostat, The serum concentration of Panobinostat can be increased when it is combined with Rivaroxaban.]
[J05AP07, daclatasvir, Daclatasvir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AA11, tioclomarol, Tioclomarol may increase the anticoagulant activities of Rivaroxaban.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J05AP06, asunaprevir, The serum concentration of Rivaroxaban can be increased when it is combined with Asunaprevir.]
[B01AC25, cangrelor, Cangrelor may increase the anticoagulant activities of Rivaroxaban.]
[A04AD14, rolapitant, Rolapitant may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G02CX02, flibanserin, The serum concentration of Rivaroxaban can be increased when it is combined with Flibanserin.]
[M02AA25, aceclofenac, The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Rivaroxaban.]
[M01AB11, acemetacin, The risk or severity of bleeding and hemorrhage can be increased when Rivaroxaban is combined with Acemetacin.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC03, lansoprazole, Lansoprazole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[V03AB37, idarucizumab, Rivaroxaban may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Trabectedin.]
[J02AC05, isavuconazole, The serum concentration of Rivaroxaban can be increased when it is combined with Isavuconazole.]
[L01EB04, osimertinib, Osimertinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Rivaroxaban.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be increased when it is combined with Rivaroxaban.]
[L01XG03, ixazomib, Rivaroxaban may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[V03AB35, sugammadex, The risk or severity of bleeding and hemorrhage can be increased when Rivaroxaban is combined with Sugammadex.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AC27, selexipag, The serum concentration of Selexipag can be increased when it is combined with Rivaroxaban.]
[M04AB05, lesinurad, Rivaroxaban may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M01AE16, alminoprofen, The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Rivaroxaban.]
[N02BA02, aloxiprin, The risk or severity of bleeding can be increased when Aloxiprin is combined with Rivaroxaban.]
[N03AX23, brivaracetam, Brivaracetam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01XX52, venetoclax, The metabolism of Rivaroxaban can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, Bromazepam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Rivaroxaban may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[A05AA04, obeticholic acid, The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Obeticholic acid.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, Levobupivacaine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N07BC01, buprenorphine, Buprenorphine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01AB01, busulfan, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Busulfan.]
[L01XX27, arsenic trioxide, The serum concentration of Rivaroxaban can be increased when it is combined with Arsenic trioxide.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Rivaroxaban.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01GX07, azelastine, The metabolism of Rivaroxaban can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, Rucaparib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01AA26, azithromycin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Rivaroxaban.]
[L01EF02, ribociclib, The metabolism of Rivaroxaban can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Rivaroxaban.]
[A06AH05, naldemedine, Rivaroxaban may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Rivaroxaban may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[P01CA02, benznidazole, Rivaroxaban may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Rivaroxaban.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J05AE09, tipranavir, The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Rivaroxaban.]
[H03BA03, benzylthiouracil, Benzylthiouracil may increase the anticoagulant activities of Rivaroxaban.]
[N07XX13, valbenazine, Rivaroxaban may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Rivaroxaban can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Rivaroxaban can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, Brigatinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01MA23, delafloxacin, Rivaroxaban may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[B01AF04, betrixaban, Betrixaban may increase the anticoagulant activities of Rivaroxaban.]
[L01BC06, capecitabine, Capecitabine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01XX59, enasidenib, Enasidenib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EH02, neratinib, The serum concentration of Rivaroxaban can be increased when it is combined with Neratinib.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Rivaroxaban.]
[L01XH01, vorinostat, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Vorinostat.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Rivaroxaban.]
[L01EF03, abemaciclib, Abemaciclib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C07AB07, bisoprolol, The serum concentration of Rivaroxaban can be increased when it is combined with Bisoprolol.]
[J05AG03, efavirenz, The metabolism of Rivaroxaban can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01BA03, raltitrexed, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Raltitrexed.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The metabolism of Rivaroxaban can be increased when combined with Budesonide.]
[C04AX20, buflomedil, Buflomedil may increase the anticoagulant activities of Rivaroxaban.]
[M01AB07, bumadizone, The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Rivaroxaban.]
[L01EL02, acalabrutinib, The metabolism of Rivaroxaban can be decreased when combined with Acalabrutinib.]
[J05AX18, letermovir, Letermovir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B02BX06, emicizumab, The therapeutic efficacy of Emicizumab can be decreased when used in combination with Rivaroxaban.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Rivaroxaban may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[L02BB05, apalutamide, The serum concentration of Rivaroxaban can be decreased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The serum concentration of Rivaroxaban can be decreased when it is combined with Carbamazepine.]
[H03BB01, carbimazole, Carbimazole may increase the anticoagulant activities of Rivaroxaban.]
[L03AB06, interferon alfa-n1, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon alfa-n1.]
[C07AG02, carvedilol, The serum concentration of Rivaroxaban can be increased when it is combined with Carvedilol.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[V03AB38, andexanet alfa, The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Rivaroxaban.]
[N03AX24, cannabidiol, Cannabidiol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B02BX08, avatrombopag, Avatrombopag may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L04AA37, baricitinib, Rivaroxaban may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Rivaroxaban.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01GB14, plazomicin, Rivaroxaban may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[H01CC03, elagolix, The serum concentration of Rivaroxaban can be increased when it is combined with Elagolix.]
[L01XX62, ivosidenib, The metabolism of Rivaroxaban can be increased when combined with Ivosidenib.]
[A16AX14, migalastat, Migalastat may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Rivaroxaban can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, The serum concentration of Lusutrombopag can be increased when it is combined with Rivaroxaban.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Rivaroxaban.]
[L01EM04, duvelisib, The serum concentration of Duvelisib can be increased when it is combined with Rivaroxaban.]
[L01EB07, dacomitinib, Dacomitinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01AA14, sarecycline, The serum concentration of Rivaroxaban can be increased when it is combined with Sarecycline.]
[J01AA15, omadacycline, The serum concentration of Omadacycline can be increased when it is combined with Rivaroxaban.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[D08AE05, chloroxylenol, Rivaroxaban may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Rivaroxaban.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01XK04, talazoparib, The serum concentration of Talazoparib can be increased when it is combined with Rivaroxaban.]
[R03BB08, revefenacin, The serum concentration of Revefenacin can be increased when it is combined with Rivaroxaban.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Rivaroxaban.]
[L04AA39, emapalumab, The metabolism of Rivaroxaban can be increased when combined with Emapalumab.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EX12, larotrectinib, The serum concentration of Larotrectinib can be increased when it is combined with Rivaroxaban.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01XJ03, glasdegib, Glasdegib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[A06AX05, prucalopride, Rivaroxaban may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AX07, caplacizumab, Caplacizumab may increase the anticoagulant activities of Rivaroxaban.]
[B01AC23, cilostazol, Cilostazol may increase the anticoagulant activities of Rivaroxaban.]
[J01FA09, clarithromycin, The metabolism of Rivaroxaban can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, Rivaroxaban may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[L01EN01, erdafitinib, The serum concentration of Rivaroxaban can be increased when it is combined with Erdafitinib.]
[N05BA09, clobazam, The serum concentration of Rivaroxaban can be increased when it is combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Rivaroxaban can be increased when combined with Cloprednol.]
[L04AB01, etanercept, The metabolism of Rivaroxaban can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Rivaroxaban can be increased when combined with Cortivazol.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L02BB06, darolutamide, The serum concentration of Rivaroxaban can be increased when it is combined with Darolutamide.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EX14, entrectinib, The serum concentration of Rivaroxaban can be increased when it is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Rivaroxaban can be decreased when it is combined with Pitolisant.]
[J01XX12, lefamulin, The serum concentration of Lefamulin can be increased when it is combined with Rivaroxaban.]
[N04CX01, istradefylline, Istradefylline may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, The serum concentration of Rivaroxaban can be increased when it is combined with Daptomycin.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G03DB05, demegestone, The risk or severity of adverse effects can be increased when Demegestone is combined with Rivaroxaban.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Rivaroxaban.]
[N02CC08, lasmiditan, The serum concentration of Rivaroxaban can be increased when it is combined with Lasmiditan.]
[G03AC09, desogestrel, The risk or severity of adverse effects can be increased when Desogestrel is combined with Rivaroxaban.]
[N03AX25, cenobamate, The serum concentration of Rivaroxaban can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M09AX08, golodirsen, Rivaroxaban may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Rivaroxaban.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be increased when it is combined with Rivaroxaban.]
[S01XA12, dexpanthenol, Rivaroxaban may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be increased when it is combined with Rivaroxaban.]
[L01XX72, tazemetostat, The serum concentration of Tazemetostat can be increased when it is combined with Rivaroxaban.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Rivaroxaban.]
[H02CA02, osilodrostat, The metabolism of Rivaroxaban can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Rivaroxaban can be decreased when combined with Amprenavir.]
[G04CB02, dutasteride, The metabolism of Rivaroxaban can be decreased when combined with Dutasteride.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be increased when it is combined with Rivaroxaban.]
[R02AA03, dichlorobenzyl alcohol, Rivaroxaban may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, The risk or severity of adverse effects can be increased when Dienogest is combined with Rivaroxaban.]
[M01AH02, rofecoxib, The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Rivaroxaban.]
[L01XF03, bexarotene, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Bexarotene.]
[C08CA16, clevidipine, Clevidipine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Rivaroxaban.]
[L01AA02, chlorambucil, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Chlorambucil.]
[S03AA08, chloramphenicol, The metabolism of Rivaroxaban can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, Tucatinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EX17, capmatinib, The serum concentration of Rivaroxaban can be increased when it is combined with Capmatinib.]
[D07XB03, fluprednidene, The metabolism of Rivaroxaban can be increased when combined with Fluprednidene.]
[M01AC04, droxicam, The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Rivaroxaban.]
[L01EX19, ripretinib, Ripretinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[V08CA05, mangafodipir, Rivaroxaban may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[B01AE02, lepirudin, Lepirudin may increase the anticoagulant activities of Rivaroxaban.]
[M02AA27, dexketoprofen, The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Rivaroxaban.]
[C08CA17, levamlodipine, The metabolism of Levamlodipine can be decreased when combined with Rivaroxaban.]
[J05AX29, fostemsavir, Fostemsavir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01FX15, belantamab mafodotin, The serum concentration of Belantamab mafodotin can be increased when it is combined with Rivaroxaban.]
[L04AC19, satralizumab, The serum concentration of Rivaroxaban can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, Chloroquine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA06, chlorotrianisene, Chlorotrianisene may decrease the anticoagulant activities of Rivaroxaban.]
[R06AB04, chlorpheniramine, The metabolism of Rivaroxaban can be decreased when combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N02BA07, ethenzamide, The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Rivaroxaban.]
[N02BA03, choline salicylate, The risk or severity of bleeding can be increased when Choline salicylate is combined with Rivaroxaban.]
[G03DC06, ethynodiol, The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Etynodiol.]
[M01AB08, etodolac, The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Rivaroxaban.]
[M02AA06, etofenamate, The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Rivaroxaban.]
[B06AC06, berotralstat, The metabolism of Rivaroxaban can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Rivaroxaban can be decreased when combined with Lonafarnib.]
[L01BB05, fludarabine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Fludarabine.]
[L02BX04, relugolix, The serum concentration of Relugolix can be increased when it is combined with Rivaroxaban.]
[M01AX25, chondroitin sulfates, Rivaroxaban may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L04AD03, voclosporin, The serum concentration of Rivaroxaban can be increased when it is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Rivaroxaban can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The serum concentration of Rivaroxaban can be increased when it is combined with Tepotinib.]
[L01EX25, umbralisib, The serum concentration of Rivaroxaban can be increased when it is combined with Umbralisib.]
[V03AF12, trilaciclib, The serum concentration of Trilaciclib can be increased when it is combined with Rivaroxaban.]
[M01AE05, fenbufen, The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Rivaroxaban.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G04CB01, finasteride, The metabolism of Rivaroxaban can be decreased when combined with Finasteride.]
[J01DD08, cefixime, The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Cefixime.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N02BG07, flupirtine, Rivaroxaban may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be decreased when combined with Rivaroxaban.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L03AB10, peginterferon alfa-2b, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Peginterferon alfa-2b.]
[L01FX22, loncastuximab tesirine, The serum concentration of Loncastuximab tesirine can be increased when it is combined with Rivaroxaban.]
[A02BA01, cimetidine, The metabolism of Rivaroxaban can be decreased when combined with Cimetidine.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01XX73, sotorasib, The serum concentration of Rivaroxaban can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Rivaroxaban can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, Rivaroxaban may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The risk or severity of hemorrhage can be increased when Citalopram is combined with Rivaroxaban.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA48, belumosudil, Belumosudil may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Rivaroxaban.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be decreased when combined with Rivaroxaban.]
[V09AB03, ioflupane I-123, Rivaroxaban may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Rivaroxaban may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09GA01, technetium Tc 99m sestamibi, The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Rivaroxaban.]
[V09AX06, florbetaben f-18, Rivaroxaban may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[M01AG01, mefenamic acid, The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Rivaroxaban.]
[J01FF01, clindamycin, The metabolism of Rivaroxaban can be decreased when combined with Clindamycin.]
[N06AX25, St. John's wort extract, The metabolism of Rivaroxaban can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The serum concentration of Rivaroxaban can be increased when it is combined with Asciminib.]
[J05AX10, maribavir, Maribavir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The serum concentration of Rivaroxaban can be increased when it is combined with Abrocitinib.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AD11, tenecteplase, Tenecteplase may increase the anticoagulant activities of Rivaroxaban.]
[B06AX04, mitapivat, The serum concentration of Rivaroxaban can be increased when it is combined with Mitapivat.]
[N01BB10, levobupivacaine, Levobupivacaine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EJ03, pacritinib, The serum concentration of Rivaroxaban can be increased when it is combined with Pacritinib.]
[G03GB02, clomiphene, The serum concentration of Rivaroxaban can be increased when it is combined with Clomifene.]
[N06AA04, clomipramine, Clomipramine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N03AE01, clonazepam, Clonazepam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Rivaroxaban.]
[C01EB24, mavacamten, The serum concentration of Rivaroxaban can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J02AC06, oteseconazole, The serum concentration of Rivaroxaban can be increased when it is combined with Oteseconazole.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Rivaroxaban.]
[A04AA01, ondansetron, The metabolism of Rivaroxaban can be decreased when combined with Ondansetron.]
[L01XX77, adagrasib, The serum concentration of Rivaroxaban can be increased when it is combined with Adagrasib.]
[N05AH02, clozapine, The metabolism of Rivaroxaban can be decreased when combined with Clozapine.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be increased when it is combined with Rivaroxaban.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01GB12, arbekacin, Rivaroxaban may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Rivaroxaban can be increased when combined with Somatrogon.]
[L04AC21, bimekizumab, The metabolism of Rivaroxaban can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Rivaroxaban.]
[M04AC01, colchicine, The serum concentration of Rivaroxaban can be increased when it is combined with Colchicine.]
[J01XB01, colistin, Rivaroxaban may decrease the excretion rate of Colistin which could result in a higher serum level.]
[L01XX40, omacetaxine mepesuccinate, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Omacetaxine mepesuccinate.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[A04AA03, tropisetron, Rivaroxaban may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Rivaroxaban.]
[L01BB07, nelarabine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Nelarabine.]
[J01FA15, telithromycin, The metabolism of Rivaroxaban can be decreased when combined with Telithromycin.]
[B01AC10, indobufen, Indobufen may increase the anticoagulant activities of Rivaroxaban.]
[J05AB14, valganciclovir, Valganciclovir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C05BB03, invert sugar, Rivaroxaban may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Iodixanol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[V08AB05, iopromide, Rivaroxaban may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Rivaroxaban may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Rivaroxaban may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Rivaroxaban.]
[N02CC05, almotriptan, Almotriptan may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M01AH04, parecoxib, The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Rivaroxaban.]
[J02AC02, itraconazole, The metabolism of Rivaroxaban can be decreased when combined with Itraconazole.]
[B01AB12, bemiparin, Bemiparin may increase the anticoagulant activities of Rivaroxaban.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N05BA10, ketazolam, Ketazolam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M01AA06, kebuzone, The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Rivaroxaban.]
[L01EA01, imatinib, Imatinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J02AC04, posaconazole, The metabolism of Rivaroxaban can be decreased when combined with Posaconazole.]
[N03AX09, lamotrigine, Lamotrigine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01BA03, cortisone, The metabolism of Rivaroxaban can be increased when combined with Cortisone.]
[N07BC04, lofexidine, Lofexidine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M01AB09, lonazolac, The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Rivaroxaban.]
[M02AA31, loxoprofen, The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Rivaroxaban.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Rivaroxaban may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[H02AB15, meprednisone, The metabolism of Rivaroxaban can be increased when combined with Meprednisone.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Rivaroxaban may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, The serum concentration of Rivaroxaban can be increased when it is combined with Tenofovir disoproxil.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Rivaroxaban.]
[N06AX07, minaprine, The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Rivaroxaban.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be decreased when combined with Rivaroxaban.]
[N06AG02, moclobemide, The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Rivaroxaban.]
[N06BA07, modafinil, The metabolism of Rivaroxaban can be increased when combined with Modafinil.]
[C10AA07, rosuvastatin, The metabolism of Rivaroxaban can be decreased when combined with Rosuvastatin.]
[M02AA02, mofebutazone, The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Rivaroxaban.]
[M01AX22, morniflumate, The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Rivaroxaban.]
[C03XA02, conivaptan, The metabolism of Rivaroxaban can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Cytarabine.]
[G04BE09, vardenafil, The serum concentration of Rivaroxaban can be increased when it is combined with Vardenafil.]
[M01AH05, etoricoxib, The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Rivaroxaban.]
[L01AX04, dacarbazine, Dacarbazine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01DA01, dactinomycin, The serum concentration of Dactinomycin can be increased when it is combined with Rivaroxaban.]
[G03XA01, danazol, The metabolism of Rivaroxaban can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Rivaroxaban can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The metabolism of Rivaroxaban can be increased when combined with Daunorubicin.]
[M01AX01, nabumetone, The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Rivaroxaban.]
[B02BD03, anti-inhibitor coagulant complex, The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Rivaroxaban.]
[N07BB05, nalmefene, Rivaroxaban may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N06AX06, nefazodone, The metabolism of Rivaroxaban can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, Rivaroxaban may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G03DB04, nomegestrol, The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Nomegestrol.]
[B01AX05, fondaparinux, Fondaparinux may increase the anticoagulant activities of Rivaroxaban.]
[N06AB10, escitalopram, The risk or severity of bleeding can be increased when Escitalopram is combined with Rivaroxaban.]
[A07EC03, olsalazine, The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Rivaroxaban.]
[N06AA01, desipramine, Desipramine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[V04CH02, indigo carmine, Rivaroxaban may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01XA03, oxaliplatin, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Oxaliplatin.]
[M01AE12, oxaprozin, The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Rivaroxaban.]
[N03AF02, oxcarbazepine, The metabolism of Rivaroxaban can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Rivaroxaban can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Rivaroxaban can be decreased when combined with Oxybutynin.]
[L04AB04, adalimumab, The metabolism of Rivaroxaban can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, Gefitinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R05DA09, dextromethorphan, The metabolism of Rivaroxaban can be decreased when combined with Dextromethorphan.]
[N06AB05, paroxetine, The risk or severity of hemorrhage can be increased when Paroxetine is combined with Rivaroxaban.]
[B01AC04, clopidogrel, Clopidogrel may increase the anticoagulant activities of Rivaroxaban.]
[C01DA05, pentaerythritol tetranitrate, Pentaerythritol tetranitrate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[P03AC04, permethrin, Permethrin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N05BA01, diazepam, Diazepam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R05DA08, pholcodine, Rivaroxaban may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Rivaroxaban.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01DC04, ixabepilone, The serum concentration of Rivaroxaban can be increased when it is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Rivaroxaban.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the anticoagulant activities of Rivaroxaban.]
[C08CA03, isradipine, The metabolism of Rivaroxaban can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Rivaroxaban can be increased when combined with Difluocortolone.]
[N02BA11, diflunisal, The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Rivaroxaban.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Rivaroxaban.]
[C01AA05, digoxin, Rivaroxaban may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[L02AA02, polyestradiol phosphate, Polyestradiol phosphate may decrease the anticoagulant activities of Rivaroxaban.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Rivaroxaban can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The risk or severity of bleeding can be increased when Treprostinil is combined with Rivaroxaban.]
[H03BC01, potassium perchlorate, Potassium perchlorate may increase the anticoagulant activities of Rivaroxaban.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DB01, diltiazem, The metabolism of Rivaroxaban can be decreased when combined with Diltiazem.]
[V03AB09, dimercaprol, Rivaroxaban may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Dimethyl sulfoxide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N02BB04, propyphenazone, The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Rivaroxaban.]
[M01AB14, proglumetacin, The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Rivaroxaban.]
[C05CA03, diosmin, The serum concentration of Rivaroxaban can be increased when it is combined with Diosmin.]
[B01AC07, dipyridamole, Dipyridamole may increase the anticoagulant activities of Rivaroxaban.]
[B01AD10, drotrecogin alfa, Drotrecogin alfa may increase the anticoagulant activities of Rivaroxaban.]
[A03FA02, cisapride, The metabolism of Rivaroxaban can be decreased when combined with Cisapride.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Rivaroxaban.]
[S01AX06, resorcinol, Rivaroxaban may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[P03AA04, disulfiram, The metabolism of Rivaroxaban can be decreased when combined with Disulfiram.]
[S02AA12, rifamycin SV, The metabolism of Rivaroxaban can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Rivaroxaban can be increased when combined with Rifapentine.]
[N05AX08, risperidone, The metabolism of Rivaroxaban can be decreased when combined with Risperidone.]
[R06AE09, levocetirizine, Rivaroxaban may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, Ropivacaine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Rivaroxaban.]
[A04AD12, aprepitant, The metabolism of Rivaroxaban can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be increased when it is combined with Rivaroxaban.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01BC05, ketorolac, The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Rivaroxaban.]
[C02KX02, ambrisentan, The serum concentration of Ambrisentan can be increased when it is combined with Rivaroxaban.]
[C01EB18, ranolazine, The serum concentration of Rivaroxaban can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Rivaroxaban.]
[R03AC12, salmeterol, The metabolism of Rivaroxaban can be decreased when combined with Salmeterol.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[A03FA03, domperidone, The metabolism of Rivaroxaban can be decreased when combined with Domperidone.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N06AA12, doxepin, Doxepin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01DB01, doxorubicin, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Doxorubicin.]
[J01AA02, doxycycline, The risk or severity of bleeding can be increased when Doxycycline is combined with Rivaroxaban.]
[N06AB06, sertraline, The risk or severity of bleeding can be increased when Sertraline is combined with Rivaroxaban.]
[A08AA10, sibutramine, The risk or severity of hemorrhage can be increased when Sibutramine is combined with Rivaroxaban.]
[C10AA01, simvastatin, The serum concentration of Rivaroxaban can be increased when it is combined with Simvastatin.]
[A12CA02, sodium sulfate, Rivaroxaban may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[G03DB01, dydrogesterone, Dydrogesterone may decrease the anticoagulant activities of Rivaroxaban.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C07AB13, talinolol, The serum concentration of Talinolol can be increased when it is combined with Rivaroxaban.]
[J01CG02, tazobactam, The risk or severity of bleeding can be increased when Tazobactam is combined with Rivaroxaban.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M01AC02, tenoxicam, The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Rivaroxaban.]
[G03CX01, tibolone, Tibolone may increase the anticoagulant activities of Rivaroxaban.]
[M01AG02, tolfenamic acid, The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Rivaroxaban.]
[N06AG03, toloxatone, The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Rivaroxaban.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L02BA02, toremifene, The risk or severity of bleeding can be increased when Toremifene is combined with Rivaroxaban.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Chloral hydrate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AC18, triflusal, Triflusal may increase the anticoagulant activities of Rivaroxaban.]
[C05CA04, troxerutin, Troxerutin may increase the anticoagulant activities of Rivaroxaban.]
[L01CA04, vinorelbine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Vinorelbine.]
[N06AX16, venlafaxine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Venlafaxine.]
[C08CA12, mepirodipine, The metabolism of Rivaroxaban can be decreased when combined with Barnidipine.]
[L01DB03, epirubicin, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Epirubicin.]
[M01AB04, zomepirac, The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Rivaroxaban.]
[N03AX15, zonisamide, The serum concentration of Rivaroxaban can be increased when it is combined with Zonisamide.]
[B01AD03, anistreplase, Anistreplase may increase the anticoagulant activities of Rivaroxaban.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AC11, iloprost, Iloprost may increase the anticoagulant activities of Rivaroxaban.]
[N02CA02, ergotamine, The metabolism of Rivaroxaban can be decreased when combined with Ergotamine.]
[L03AX05, pidotimod, Rivaroxaban may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The risk or severity of bleeding can be increased when Erythromycin is combined with Rivaroxaban.]
[N05CD04, estazolam, Estazolam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G03CA03, estradiol, The risk or severity of adverse effects can be increased when Estradiol is combined with Rivaroxaban.]
[G03CC06, estriol, Estriol may decrease the anticoagulant activities of Rivaroxaban.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Rivaroxaban.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The metabolism of Rivaroxaban can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Rivaroxaban can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Rivaroxaban can be decreased when combined with Fluvastatin.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L02AA03, ethinyl estradiol, The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Rivaroxaban.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M01AC06, meloxicam, The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Rivaroxaban.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Rivaroxaban.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Rivaroxaban.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Rivaroxaban.]
[R06AX12, terfenadine, The metabolism of Rivaroxaban can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Trimetrexate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N06AX12, bupropion, Bupropion may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N06AB08, fluvoxamine, The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Rivaroxaban.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C10AA03, pravastatin, Pravastatin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Rivaroxaban may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B02BD08, factor VIIa, The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Rivaroxaban.]
[B02BD14, antihemophilic factor, porcine B-domain truncated recombinant, The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Rivaroxaban.]
[A05AA01, chenodeoxycholic acid, The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Chenodeoxycholic acid.]
[D11AX24, deoxycholic acid, The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Deoxycholic acid.]
[B05AA05, dextran, Dextran may increase the anticoagulant activities of Rivaroxaban.]
[B02BD11, coagulation factor XIII a-subunit (recombinant), The therapeutic efficacy of Catridecacog can be decreased when used in combination with Rivaroxaban.]
[B02BD07, factor XIII, The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Rivaroxaban.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[A16AA01, levocarnitine, The therapeutic efficacy of Rivaroxaban can be increased when used in combination with Levocarnitine.]
[C08CA02, felodipine, The metabolism of Rivaroxaban can be decreased when combined with Felodipine.]
[M01AE04, fenoprofen, The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Rivaroxaban.]
[N02AB03, fentanyl, Fentanyl may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B02BB01, fibrinogen, human, The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Rivaroxaban.]
[B01AD05, plasmin, Fibrinolysin may increase the anticoagulant activities of Rivaroxaban.]
[L01BB06, clofarabine, Clofarabine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L04AA40, cladribine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Cladribine.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G04BD02, flavoxate, Flavoxate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N02BG04, floctafenine, The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Rivaroxaban.]
[J02AC01, fluconazole, The metabolism of Rivaroxaban can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, Flucytosine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[V03AB25, flumazenil, Flumazenil may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[D07AC08, fluocinonide, The metabolism of Rivaroxaban can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Rivaroxaban can be increased when combined with Fluocortolone.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01BC02, fluorouracil, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Fluorouracil.]
[N06AB03, fluoxetine, The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Rivaroxaban.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01BC04, flurbiprofen, The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Rivaroxaban.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Rivaroxaban.]
[G01AX06, furazolidone, The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Rivaroxaban.]
[J05AE10, darunavir, The serum concentration of Rivaroxaban can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01AD09, ganciclovir, Ganciclovir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C10AB04, gemfibrozil, Gemfibrozil may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01XA03, telavancin, Rivaroxaban may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Rivaroxaban.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be increased when it is combined with Rivaroxaban.]
[G03XA02, gestrinone, The risk or severity of adverse effects can be increased when Gestrinone is combined with Rivaroxaban.]
[L02AB03, gestronol, Gestonorone may decrease the anticoagulant activities of Rivaroxaban.]
[N01AH02, alfentanil, The metabolism of Rivaroxaban can be decreased when combined with Alfentanil.]
[L01EH01, lapatinib, The serum concentration of Rivaroxaban can be increased when it is combined with Lapatinib.]
[A10BB01, glyburide, The metabolism of Rivaroxaban can be decreased when combined with Glyburide.]
[A10BB07, glipizide, Glipizide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Rivaroxaban.]
[M01CB04, aurothioglucose, Rivaroxaban may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Pegaptanib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AA12, fluindione, Fluindione may increase the anticoagulant activities of Rivaroxaban.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01EX01, guanethidine, Guanethidine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[P01BX01, halofantrine, The metabolism of Rivaroxaban can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Rivaroxaban.]
[N05AH04, quetiapine, Quetiapine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N06BX13, idebenone, Rivaroxaban may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[L01CE02, irinotecan, The metabolism of Rivaroxaban can be decreased when combined with Irinotecan.]
[B06AB01, hemin, Hemin may increase the anticoagulant activities of Rivaroxaban.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01XA14, heparin, Heparin may increase the anticoagulant activities of Rivaroxaban.]
[G03DC01, allylestrenol, Allylestrenol may decrease the anticoagulant activities of Rivaroxaban.]
[A07EC02, mesalamine, The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Rivaroxaban.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01XX03, altretamine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Altretamine.]
[J05AG01, nevirapine, The metabolism of Rivaroxaban can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Rivaroxaban can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, Nimesulide may increase the anticoagulant activities of Rivaroxaban.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C02DB02, hydralazine, Hydralazine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[S02BA01, hydrocortisone, The metabolism of Rivaroxaban can be decreased when combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Rivaroxaban may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G04BD06, propiverine, Rivaroxaban may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Rivaroxaban may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[G03DA03, 17-alpha-hydroxyprogesterone, Hydroxyprogesterone may decrease the anticoagulant activities of Rivaroxaban.]
[L01XX05, hydroxyurea, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Hydroxyurea.]
[N05BB01, hydroxyzine, The metabolism of Rivaroxaban can be decreased when combined with Hydroxyzine.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B05XA08, sodium acetate, Rivaroxaban may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[B05CB02, sodium citrate, Sodium citrate may increase the anticoagulant activities of Rivaroxaban.]
[L01DB06, idarubicin, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Idarubicin.]
[L01AA06, ifosfamide, The risk or severity of bleeding can be increased when Ifosfamide is combined with Rivaroxaban.]
[N06AA02, imipramine, The serum concentration of Imipramine can be increased when it is combined with Rivaroxaban.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Rivaroxaban.]
[R01AD07, tixocortol, Rivaroxaban may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[L01CE01, topotecan, The serum concentration of Topotecan can be increased when it is combined with Rivaroxaban.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Rivaroxaban.]
[A11HA07, inositol, Rivaroxaban may decrease the excretion rate of Inositol which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon alfa-2a.]
[L03AB05, interferon alfa-2b, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon alfa-2b.]
[N06AX17, milnacipran, The risk or severity of hemorrhage can be increased when Milnacipran is combined with Rivaroxaban.]
[D03BA02, collagenase, The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Collagenase clostridium histolyticum.]
[S01XA28, varenicline, Varenicline may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[A10BH01, sitagliptin, The serum concentration of Rivaroxaban can be increased when it is combined with Sitagliptin.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N05CH02, ramelteon, Ramelteon may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C10AA06, cerivastatin, The metabolism of Rivaroxaban can be decreased when combined with Cerivastatin.]
[L01XX35, anagrelide, Anagrelide may increase the anticoagulant activities of Rivaroxaban.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AB09, interferon alfacon-1, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon alfacon-1.]
[V03AB01, ipecac, Rivaroxaban may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AF05, iproniazid, The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Rivaroxaban.]
[N06AF01, isocarboxazid, The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Rivaroxaban.]
[J04AC01, isoniazid, The metabolism of Rivaroxaban can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Rivaroxaban may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[D10BA01, isotretinoin, Isotretinoin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AE06, bivalirudin, Bivalirudin may increase the anticoagulant activities of Rivaroxaban.]
[C04AF01, kininogenase, The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Rivaroxaban.]
[S01AA24, kanamycin, Rivaroxaban may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Rivaroxaban can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Ketamine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C02KD01, ketanserin, Ketanserin may increase the anticoagulant activities of Rivaroxaban.]
[B01AC22, prasugrel, Prasugrel may increase the anticoagulant activities of Rivaroxaban.]
[J02AB02, ketoconazole, The metabolism of Rivaroxaban can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Rivaroxaban can be decreased when combined with Levoketoconazole.]
[M02AA10, ketoprofen, The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Rivaroxaban.]
[V03AC03, deferasirox, The risk or severity of gastrointestinal bleeding can be increased when Rivaroxaban is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Rivaroxaban can be increased when combined with Abatacept.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Rivaroxaban.]
[C07AG01, labetalol, Labetalol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N04BB01, amantadine, Amantadine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[A06AX03, lubiprostone, Lubiprostone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[L01DC03, mitomycin, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Mitomycin.]
[G03AD01, levonorgestrel, The risk or severity of adverse effects can be increased when Levonorgestrel is combined with Rivaroxaban.]
[S02DA01, lidocaine, The metabolism of Rivaroxaban can be decreased when combined with Lidocaine.]
[S01AA21, amikacin, Rivaroxaban may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Rivaroxaban can be increased when combined with Armodafinil.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[L01AD02, lomustine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Lomustine.]
[A07DA03, loperamide, The serum concentration of Rivaroxaban can be increased when it is combined with Loperamide.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Rivaroxaban can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The serum concentration of Rivaroxaban can be increased when it is combined with Loxapine.]
[G03DC03, lynestrenol, The risk or severity of adverse effects can be increased when Lynestrenol is combined with Rivaroxaban.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Rivaroxaban.]
[B05XA11, magnesium chloride, Rivaroxaban may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Rivaroxaban may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, Rivaroxaban may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Rivaroxaban can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Maprotiline may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01AA05, mechlorethamine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Mechlorethamine.]
[M02AA18, meclofenamic acid, The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Rivaroxaban.]
[G03DB03, medrogestone, Medrogestone may decrease the anticoagulant activities of Rivaroxaban.]
[P01BC02, mefloquine, The serum concentration of Rivaroxaban can be increased when it is combined with Mefloquine.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, Nadroparin may increase the anticoagulant activities of Rivaroxaban.]
[B01AB05, enoxaparin, Enoxaparin may increase the anticoagulant activities of Rivaroxaban.]
[B01AB04, dalteparin, Dalteparin may increase the anticoagulant activities of Rivaroxaban.]
[L01AA03, melphalan, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Melphalan.]
[N06DX01, memantine, Memantine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N01BB03, mepivacaine, Mepivacaine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G04BX16, tiopronin, Rivaroxaban may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, The serum concentration of Rivaroxaban can be increased when it is combined with Paliperidone.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N06BA03, methamphetamine, Metamfetamine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, The metabolism of Rivaroxaban can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Rivaroxaban may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Methyldopa may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[V04CG05, methylene blue, The serum concentration of Rivaroxaban can be increased when it is combined with Methylene blue.]
[G03EK01, methyltestosterone, Rivaroxaban may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, Metoclopramide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Metoprolol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[P01AB01, metronidazole, The metabolism of Rivaroxaban can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, Metyrapone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S02AA13, miconazole, The metabolism of Rivaroxaban can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Rivaroxaban.]
[B01AB07, parnaparin, Parnaparin may increase the anticoagulant activities of Rivaroxaban.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G03XB01, mifepristone, The risk or severity of adverse effects can be increased when Mifepristone is combined with Rivaroxaban.]
[B01AB10, tinzaparin, Tinzaparin may increase the anticoagulant activities of Rivaroxaban.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01XX23, mitotane, The metabolism of Rivaroxaban can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Mitoxantrone.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C01BD01, amiodarone, The metabolism of Rivaroxaban can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N02AA01, morphine, The serum concentration of Rivaroxaban can be increased when it is combined with Morphine.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Rivaroxaban can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, Eltrombopag may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G04BA01, ammonium chloride, Rivaroxaban may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be increased when it is combined with Rivaroxaban.]
[L04AA06, mycophenolic acid, Mycophenolic acid may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G04CA04, silodosin, The serum concentration of Rivaroxaban can be increased when it is combined with Silodosin.]
[N03AB05, fosphenytoin, The metabolism of Rivaroxaban can be increased when combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon beta-1b.]
[C07AA12, nadolol, Nadolol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01CA04, amoxicillin, Amoxicillin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[V03AB15, naloxone, The metabolism of Rivaroxaban can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Rivaroxaban can be increased when combined with Anakinra.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M02AA12, naproxen, The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Rivaroxaban.]
[A10BG01, troglitazone, The metabolism of Rivaroxaban can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The risk or severity of hemorrhage can be increased when Duloxetine is combined with Rivaroxaban.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Rivaroxaban.]
[S03AA01, neomycin, Rivaroxaban may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC17, tirofiban, Tirofiban may increase the anticoagulant activities of Rivaroxaban.]
[N05AX14, iloperidone, The metabolism of Rivaroxaban can be decreased when combined with Iloperidone.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L03AX16, plerixafor, Rivaroxaban may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Rivaroxaban may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Rivaroxaban.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M04AA03, febuxostat, The excretion of Rivaroxaban can be decreased when combined with Febuxostat.]
[C01CE01, inamrinone, Amrinone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01XX01, amsacrine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Amsacrine.]
[N06AF02, nialamide, The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Rivaroxaban.]
[C08CA04, nicardipine, The metabolism of Rivaroxaban can be decreased when combined with Nicardipine.]
[C08CA05, nifedipine, Nifedipine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M02AA17, niflumic acid, The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Rivaroxaban.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08CA08, nitrendipine, The metabolism of Rivaroxaban can be decreased when combined with Nitrendipine.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G03DC02, norethindrone, The risk or severity of adverse effects can be increased when Norethisterone is combined with Rivaroxaban.]
[G03AC07, norgestrienone, The risk or severity of adverse effects can be increased when Norgestrienone is combined with Rivaroxaban.]
[N06AA10, nortriptyline, The serum concentration of Nortriptyline can be increased when it is combined with Rivaroxaban.]
[A16AX07, sapropterin, The serum concentration of Rivaroxaban can be increased when it is combined with Sapropterin.]
[B01AC16, eptifibatide, Eptifibatide may increase the anticoagulant activities of Rivaroxaban.]
[B01AB08, reviparin, Reviparin may increase the anticoagulant activities of Rivaroxaban.]
[L04AC04, rilonacept, The metabolism of Rivaroxaban can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N02AA02, opium, Rivaroxaban may decrease the excretion rate of Opium which could result in a higher serum level.]
[B01AD07, reteplase, Reteplase may increase the anticoagulant activities of Rivaroxaban.]
[B01AD09, ancrod, Ancrod may increase the anticoagulant activities of Rivaroxaban.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N02AA05, oxycodone, The metabolism of Rivaroxaban can be decreased when combined with Oxycodone.]
[S01BC02, oxyphenbutazone, The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Rivaroxaban.]
[J04AA01, aminosalicylic acid, The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Rivaroxaban.]
[B01AB09, danaparoid, Danaparoid may increase the anticoagulant activities of Rivaroxaban.]
[J04AB30, capreomycin, Rivaroxaban may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G03DB06, chlormadinone, The risk or severity of adverse effects can be increased when Chlormadinone is combined with Rivaroxaban.]
[H02AB05, paramethasone, The metabolism of Rivaroxaban can be increased when combined with Paramethasone.]
[C02KC01, pargyline, The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Rivaroxaban.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G04BD11, fesoterodine, Rivaroxaban may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Penbutolol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M01CC01, penicillamine, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Penicillamine.]
[J01CE09, penicillin G procaine, Rivaroxaban may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The metabolism of Rivaroxaban can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Rivaroxaban may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may increase the anticoagulant activities of Rivaroxaban.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N06AF03, phenelzine, The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Rivaroxaban.]
[B01AA02, phenindione, Phenindione may increase the anticoagulant activities of Rivaroxaban.]
[N03AA02, phenobarbital, The metabolism of Rivaroxaban can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, Phenprocoumon may increase the anticoagulant activities of Rivaroxaban.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[M02AA01, phenylbutazone, The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Rivaroxaban.]
[N03AB02, phenytoin, The metabolism of Rivaroxaban can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Rivaroxaban can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Levofloxacin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08CX01, mibefradil, The serum concentration of Rivaroxaban can be increased when it is combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Rivaroxaban.]
[C07AA03, pindolol, Pindolol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C10AA05, atorvastatin, The metabolism of Rivaroxaban can be decreased when combined with Atorvastatin.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J05AE01, saquinavir, The metabolism of Rivaroxaban can be decreased when combined with Saquinavir.]
[N06BX03, piracetam, Rivaroxaban may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[S01BC06, piroxicam, The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Rivaroxaban.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J05AG02, delavirdine, The metabolism of Rivaroxaban can be decreased when combined with Delavirdine.]
[B01AC13, abciximab, Abciximab may increase the anticoagulant activities of Rivaroxaban.]
[S01XA13, alteplase, Alteplase may increase the anticoagulant activities of Rivaroxaban.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L04AC08, canakinumab, The metabolism of Rivaroxaban can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The serum concentration of Rivaroxaban can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, Rivaroxaban may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[V03AB21, potassium iodide, Potassium Iodide may increase the anticoagulant activities of Rivaroxaban.]
[P02BA01, praziquantel, The metabolism of Rivaroxaban can be decreased when combined with Praziquantel.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[P01BA03, primaquine, The metabolism of Rivaroxaban can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Rivaroxaban can be increased when combined with Primidone.]
[M04AB01, probenecid, Probenecid may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C01BA02, procainamide, Rivaroxaban may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Rivaroxaban.]
[L01XB01, procarbazine, The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Rivaroxaban.]
[C10AB05, fenofibrate, Fenofibrate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[G03DA04, progesterone, The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Progesterone.]
[G03DB07, promegestone, Promegestone may decrease the anticoagulant activities of Rivaroxaban.]
[R06AD02, promethazine, Promethazine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C01BC03, propafenone, The serum concentration of Rivaroxaban can be increased when it is combined with Propafenone.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R06AX26, fexofenadine, The serum concentration of Rivaroxaban can be increased when it is combined with Fexofenadine.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be increased when it is combined with Rivaroxaban.]
[C07AA05, propranolol, Propranolol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[H03BA02, propylthiouracil, Propylthiouracil may increase the anticoagulant activities of Rivaroxaban.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AC09, epoprostenol, Epoprostenol may increase the anticoagulant activities of Rivaroxaban.]
[N05AX12, aripiprazole, The metabolism of Rivaroxaban can be decreased when combined with Aripiprazole.]
[N07XX07, dalfampridine, Rivaroxaban may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Rivaroxaban may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[M09AB02, collagenase Clostridium histolyticum, The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Collagenase clostridium histolyticum.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[P01AX05, quinacrine, The metabolism of Rivaroxaban can be decreased when combined with Quinacrine.]
[C01BA01, quinidine, The therapeutic efficacy of Rivaroxaban can be increased when used in combination with Quinidine.]
[P01BC01, quinine, The therapeutic efficacy of Rivaroxaban can be increased when used in combination with Quinine.]
[A02BA02, ranitidine, Ranitidine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C02AA02, reserpine, The serum concentration of Rivaroxaban can be increased when it is combined with Reserpine.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Rivaroxaban can be increased when combined with Rifampicin.]
[N02BA05, salicylamide, The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Rivaroxaban.]
[A07EC01, sulfasalazine, The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Rivaroxaban.]
[S01BC08, salicylic acid, The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Rivaroxaban.]
[N05CA06, secobarbital, Secobarbital may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[N04BD01, selegiline, The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Rivaroxaban.]
[L01FA03, obinutuzumab, The risk or severity of bleeding and hemorrhage can be increased when Rivaroxaban is combined with Obinutuzumab.]
[J01GB08, sisomicin, Rivaroxaban may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Rivaroxaban may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Sorbitol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Rivaroxaban.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Rivaroxaban.]
[A05AA02, ursodiol, The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Ursodeoxycholic acid.]
